DK131295C - - Google Patents

Info

Publication number
DK131295C
DK131295C DK483769A DK483769A DK131295C DK 131295 C DK131295 C DK 131295C DK 483769 A DK483769 A DK 483769A DK 483769 A DK483769 A DK 483769A DK 131295 C DK131295 C DK 131295C
Authority
DK
Denmark
Application number
DK483769A
Other languages
Danish (da)
Other versions
DK131295B (en
Inventor
J Elks
G H Phillipps
A Tulley
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of DK131295B publication Critical patent/DK131295B/en
Application granted granted Critical
Publication of DK131295C publication Critical patent/DK131295C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK483769AA 1966-07-29 1969-09-10 Steroids of the estrane or 19-norpregnan series for use as contraceptives. DK131295B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB23066/67A GB1202521A (en) 1966-07-29 1966-07-29 01beta-CHLORO-19-NOR-STEROIDS
GB3427566 1966-07-29
DK389767AA DK129004B (en) 1966-07-29 1967-07-28 Analogous process for the preparation of 9α-unsubstituted 11β-chloro-19-norsteroids of the estrane or 19-norpregane series.

Publications (2)

Publication Number Publication Date
DK131295B DK131295B (en) 1975-06-23
DK131295C true DK131295C (en) 1975-11-17

Family

ID=26256295

Family Applications (2)

Application Number Title Priority Date Filing Date
DK389767AA DK129004B (en) 1966-07-29 1967-07-28 Analogous process for the preparation of 9α-unsubstituted 11β-chloro-19-norsteroids of the estrane or 19-norpregane series.
DK483769AA DK131295B (en) 1966-07-29 1969-09-10 Steroids of the estrane or 19-norpregnan series for use as contraceptives.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK389767AA DK129004B (en) 1966-07-29 1967-07-28 Analogous process for the preparation of 9α-unsubstituted 11β-chloro-19-norsteroids of the estrane or 19-norpregane series.

Country Status (12)

Country Link
JP (2) JPS5021469B1 (en)
AT (2) AT301766B (en)
BE (1) BE702023A (en)
CH (2) CH580644A5 (en)
DE (1) DE1668124B2 (en)
DK (2) DK129004B (en)
FR (2) FR1565340A (en)
GB (1) GB1202521A (en)
IL (1) IL28411A (en)
NL (1) NL6710459A (en)
PL (1) PL79253B1 (en)
SE (2) SE349025B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1289521A (en) * 1969-01-23 1972-09-20
GB1313659A (en) * 1969-07-25 1973-04-18 Glaxo Lab Ltd 9alpha-unsubstituted-11beta-chloro-19-norpregnane compounds
JPS5090184A (en) * 1973-12-14 1975-07-19
JPS5090183A (en) * 1973-12-14 1975-07-19

Also Published As

Publication number Publication date
PL79253B1 (en) 1975-06-30
GB1202521A (en) 1970-08-19
SE350488B (en) 1972-10-30
JPS5224013B1 (en) 1977-06-28
DE1668124B2 (en) 1976-10-07
DE1668124A1 (en) 1971-05-06
CH584724A5 (en) 1977-02-15
SE349025B (en) 1972-09-18
DK129004B (en) 1974-08-05
NL6710459A (en) 1968-01-30
IL28411A (en) 1972-07-26
FR7812M (en) 1970-05-20
CH580644A5 (en) 1976-10-15
JPS5021469B1 (en) 1975-07-23
BE702023A (en) 1968-01-29
AT311564B (en) 1973-11-26
AT301766B (en) 1972-09-25
DK131295B (en) 1975-06-23
FR1565340A (en) 1969-05-02

Similar Documents

Publication Publication Date Title
DK131295C (en)
AT281852B (en)
AU1534566A (en)
AU1141566A (en)
AU1393566A (en)
AU1144366A (en)
AU1111066A (en)
BE690950A (en)
BE688379A (en)
BE694160A (en)
BE694116A (en)
BE694550A (en)
BE693704A (en)
BE693633A (en)
BE693313A (en)
BE693055A (en)
BE693043A (en)
BE674777A (en)
BE692798A (en)
BE692317A (en)
BE674713A (en)
BE694594A (en)
BE690896A (en)
BE690197A (en)
BE689243A (en)